Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 12.12
- Piotroski Score 2.00
- Grade Buy
- Symbol (RZLT)
- Company Rezolute, Inc.
- Price $4.85
- Changes Percentage (-3.19%)
- Change -$0.16
- Day Low $4.82
- Day High $5.14
- Year High $6.19
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, a selective and potent plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/11/2025
- Fiscal Year End N/A
- Average Stock Price Target $14.00
- High Stock Price Target $15.00
- Low Stock Price Target $11.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.14
- Trailing P/E Ratio -5.02
- Forward P/E Ratio -5.02
- P/E Growth -5.02
- Net Income $-68,459,000
Income Statement
Quarterly
Annual
Latest News of RZLT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading into 2025?
A list of the 10 Best Multibagger Stocks for 2025 includes Rezolute, Inc. November saw market highs after the Fed rate cut and Trump's re-election. Fed Chair Powell highlighted economic growth and inf...
By Yahoo! Finance | 5 days ago
